血清缺血修饰性白蛋白评价不同病因肝硬化患者肝功能的意义

陈成良; 宋巍; 孟秀娜; 田兴; 焦健

doi:10.3969/j.issn.1001-5256.2016.08.020

血清缺血修饰性白蛋白评价不同病因肝硬化患者肝功能的意义

DOI: 10.3969/j.issn.1001-5256.2016.08.020

1. 吉林大学中日联谊医院
2. 陕西省西安市第四医院

详细信息

中图分类号: R575.2
计量
- 文章访问数: 2184
- HTML全文浏览量: 55
- PDF下载量: 446
- 被引次数: 0
出版历程
- 收稿日期: 2016-01-26
- 出版日期: 2016-08-20

Significance of serum ischemia-modified albumin level in evaluating liver function in patients with liver cirrhosis of various causes

China-Japan Union Hospital of Jilin University

摘要

摘要: 目的观察血清缺血修饰性白蛋白（IMA）、IMA/血清白蛋白（Alb）比值（IMAR）在不同病因肝硬化患者中的差异,探讨IMA、IMAR在评估肝功能方面的价值。方法收集2012年2月-2014年2月吉林大学中日联谊医院收治的456例肝硬化患者的病历资料。根据血清Alb水平分为Alb正常组152例、Alb降低组304例,根据病因进一步分为乙型肝炎、丙型肝炎和酒精性肝硬化组,以160例健康人群作为对照组。检测所有肝硬化患者IMA水平,计算IMAR,分析IMA、IMAR与肝功能指标和Child-Pugh评分的相关性。计量资料多组间比较采用单因素方差分析,进一步两两比较采用LSD-t检验;计数资料组间比较采用χ2检验;采用Spearman秩相关分析IMA、IMAR与Child-Pugh评分的相关性。结果与健康组比较,肝硬化患者IMA、IMAR明显升高（P值均<0.05）,其中合并低白蛋白血症肝硬化患者IMA、IMAR明显高于未合并低白蛋白血症肝硬化患者（P值均<0.01）。此外,酒精性肝硬化患者IMA水平、IMAR明显高于乙型肝炎、丙型肝炎肝硬化患者（F值分别为6.765、8.276...
- 肝硬化 /
- 血清白蛋白 /
- 低白蛋白血症
Abstract: Objective To investigate the differences in serum levels of ischemia- modified albumin( IMA) and IMA / albumin ratio( IMAR) in patients with liver cirrhosis of various causes,as well as the significance of IMA measurement and IMAR in evaluating liver function. Methods A total of 456 patients with liver cirrhosis who were admitted to China- Japan Union Hospital of Jilin University from February 2012 to February 2014 were enrolled. The patients underwent liver function evaluation,and according to the serum albumin( Alb) level,they were divided into normal Alb group( 152 patients) and reduced Alb group( 304 patients). According to the cause of the disease,the patients were further divided into hepatitis B virus( HBV) group,hepatitis C virus( HCV) group,and alcoholic cirrhosis group,and healthy subjects were enrolled as controls. The serum IMA level was measured for all patients with liver cirrhosis,IMAR was calculated,and the correlations of IMA and IMAR with liver function parameters and Child- Pugh score were analyzed. An analysis of variance was used for comparison of coutinuous data between groups,and the least significant difference t- test was used for further comparision between any two groups; the chi- square test was used for comparison of categorical data between group and the Spearman rank correlation was used to analyze the correlation of IMA、IMAR、Child- Puch score. Results Compared with the healthy controls,the patients with liver cirrhosis showed significant increases in the serum IMA level and IMAR( all P < 0. 05),and the cirrhotic patients with hypoproteinemia had significantly higher serum IMA level and IMAR than those without hypoproteinemia( all P < 0. 05). In addition,the patients with alcoholic cirrhosis had significantly higher serum IMA level and IMAR than those with HBV- or HCV- associated liver cirrhosis( F = 6. 765,8. 276; P < 0. 01).The serum IMA level was correlated with Alb,total bilirubin( TBil),international normalized ratio( INR),and cholinesterase( CHE)( r =- 0. 510,0. 731,0. 327,- 0. 679; all P < 0. 05). IMAR was correlated with TBil,INR,and CHE( r = 0. 488,0. 327,- 0. 896; all P <0. 05). The serum IMA level and IMAR were positively correlated with Child- Pugh score( r =- 0. 801,0. 899; all P < 0. 05). Conclusion Patients with liver cirrhosis experience a reduced Alb function before the development of hypoproteinemia,and serum IMA level and IMAR differ significantly between the patients with liver cirrhosis of various causes.
- liver cirrhosis /
- serum albumin /
- hypoalbuminemia

HTML全文

参考文献(12)

[1]GARCIA-MARTINEZ R,CARACENI P,BERNARDI M,et al.Albumin:pathophysiologic basis of its role in the treatment of cirrhosis and its complications[J].Hepatology,2013,58(5):1836-1846.

[2]JALAN R,SCHNURR K,MOOKERJEE RP,et al.Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality[J].Hepatology,2009,50(2):555-564.

[3]GIANNONE FA,DOMENICALI M,BALDASSARRE M,et al.Ischaemia-modified albumin:a marker of bacterial infection in hospitalized patients with cirrhosis[J].Liver Int,2015,35(11):2425-2432.

[4]Chinese Society of Infectious Diseases,Chinese Medical Association and Chinese Society of Hepatology.Pevention and treatment of viral hepatitis[J].Chin J Hepatol,2000,8(6):324-329.(in Chinese)中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329.

[5]Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese,Medical Association.The guideline of prevention and treatment for chronic hepatitis B:a 2015 update[J].J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1941-1960.

[6]BENARDI M,RICCI CS,ZACCHERINI G.Role of human albumin in the management of complications of liver cirrhosis[J].J Clin Exp Hepatol,2014,4(4):302-311.

[7]CHEN CY,TSAI WL,LIN PJ,et al.The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease[J].Clin Chem Lab Med,2011,49(11):1817-1821.

[8]BAROR D,LAU E,WINKLER JV.A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia——a preliminary report[J].J Emerg Med,2000,19(4):311-315.

[9]GUNDUZ A,TUREDI S,MENTESE A,et al.Ischemia-modified albumin in the diagnosis of acute mesenteric ischemia:a preliminary study[J].Am J Emerg Med,2008,26(2):202-205.

[10]PARVING HH,RANEK L,LASSEN NA.Increased transcapillary escape rate of albumin in patients with cirrhosis of the liver[J].Scand J Clin Lab Invest,2009,37(7):643-648.

[11] JALAN R,SCHNURR K,MOOKERJEE RP.Alterations in the functional capacity of albumin in patients with decompensatedcirrhosis is associated with increased mortality[J].Hepatology,2009,50(2):555-564.

[12]van ERPECUM KJ.Ascites and spontaneous bacterial peritonitis in patients with liver cirrhosis[J].Scand J Gastroenterol Suppl,2006,41(1):79-84.

施引文献

资源附件(0)

访问统计